WaterStone Capital
WaterStone Capital is a private investment fund manager with intellectual property as the core. It provides financing for Chinese and foreign enterprises with intellectual property content in the form of equity investment, and provides diversified support for enterprises through post-investment management, including cross-border capital operations, business docking, and resource integration. The firm is formed by a team from China and the United States. Its team members have worked in major Chinese and foreign institutions and have complementary advantages. Partners have extensive experience in international mergers and acquisitions, investment management, intellectual property rights, and independent entrepreneurship.
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Established in 2013, the company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LED) and laser technologies to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. By employing low-level light therapy, LumiThera aims to slow or halt the progression of blinding diseases, enhance visual acuity and contrast sensitivity, and reduce central drusen volume, ultimately providing healthcare providers with effective treatment options for their patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.